TORONTO -- (MARKET WIRE) -- November 09, 2006 -- Anti Aging Medical Group Corp. (PINKSHEETS: AAGM) is very pleased to announce that the company, inline with its new corporate strategy to become a leading specialty pharmaceutical company in the multi billion anti aging pharmaceutical market, has entered into the neuro-protection prescription drug market through a collaboration with AlphaRx Inc. (OTCBB: ALRX) and a group of leading neurologists.
